IMMUCELL CORP /DE/ - COM PAR (ICCC)

Q3 2020 13F Holders as of 30 Sep 2020

Type / Class
Equity / COM PAR
Number of holders
22
Total 13F shares, excl. options
713,760
Shares change
+43,040
Total reported value, excl. options
$3,875,000
Value change
+$235,295
Number of buys
4
Number of sells
-5
Price
$5.43

Significant Holders of IMMUCELL CORP /DE/ - COM PAR (ICCC) as of Q3 2020

23 filings reported holding ICCC - IMMUCELL CORP /DE/ - COM PAR as of Q3 2020.
IMMUCELL CORP /DE/ - COM PAR (ICCC) has 22 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 713,760 shares .
Largest 10 shareholders include RENAISSANCE TECHNOLOGIES LLC (156,122 shares), VANGUARD GROUP INC (93,381 shares), OVERBROOK MANAGEMENT CORP (88,025 shares), PERRITT CAPITAL MANAGEMENT INC (60,000 shares), MORGAN STANLEY (57,574 shares), SHUFRO ROSE & CO LLC (50,670 shares), Strategic Financial Services, Inc, (30,028 shares), HM PAYSON & CO (29,500 shares), GEODE CAPITAL MANAGEMENT, LLC (20,434 shares), and Essex Financial Services, Inc. (20,000 shares).
This table shows the top 22 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.